Search

Your search keyword '"Camille Vatier"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Camille Vatier" Remove constraint Author: "Camille Vatier" Topic medicine.disease Remove constraint Topic: medicine.disease
47 results on '"Camille Vatier"'

Search Results

1. The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk

2. Author response for 'Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study'

3. Monitoring gestational diabetes mellitus patients with the telemedicine application MyDiabby decreases the rate of foetal macrosomia

4. [Mutltifaceted biological roles of leptin]

5. Rôles biologiques à multiples facettes de l’adiponectine

6. Cardiovascular complications of lipodystrophic syndromes – focus on laminopathies

7. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

8. LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells

9. Author response for 'Use of Dipeptidyl Peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study'

10. Author response for 'Relationship between obesity and severe <scp>COVID</scp> ‐19 outcomes in patients with type 2 diabetes: results from the <scp>CORONADO</scp> study'

11. Added value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome

12. Blood glucose levels and COVID-19. Reply to Sardu C, D’Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]

13. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

14. Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

15. Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice

16. European lipodystrophy registry: background and structure

17. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

18. Relationship between obesity and severe COVID ‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

19. Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy

20. Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life

21. Lipodystrophic syndromes due toLMNAmutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives

22. LMNA-associated partial lipodystrophy: anticipation of metabolic complications

23. Lipodystrophic syndromes: From diagnosis to treatment

24. Monogenic forms of lipodystrophic syndromes - diagnosis, detection, and practical management considerations from clinical cases

25. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

26. Discovery of diabetes in the elderly: what diagnosis?

27. Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases

28. One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes

29. Diabetes remission after bariatric surgery in obese patients with haemochromatosis

30. Nuclear envelope-related lipodystrophies

31. Le prélèvement de tissu adipeux: un acte médical pour la recherche clinique. Perspectives pour le soin courant

32. Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy

33. Clinical Utility Gene Card for: Congenital Generalized Lipodystrophy

34. Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases

35. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes

36. Clinical Utility Gene Card for: Familial partial lipodystrophy

37. Metreleptin therapy in LMNA-linked lipodystrophies

38. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations

39. Evaluation of Visceral Fat in Massive Obesity

40. What the genetics of lipodystrophy can teach us about insulin resistance and diabetes

41. Adiponectin: An Adipokine with Multiple Faces

42. Dynamic relations between sedentary behavior, physical activity, and body composition after bariatric surgery

43. Therapeutic use of recombinant methionyl human leptin

44. A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial

45. THU0569 Bone Imaging Findings in Genetic and Acquired Lipodystrophic Syndromes: A Retrospective Study of 24 Cases

46. Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis

47. Author Correction: Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Catalog

Books, media, physical & digital resources